190A — Chordia Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Chordia Therapeutics, fiscal year end - August 31st, JPY millions except per share, conversion factor applied.

	2022 August 31st	2023 August 31st	2024 August 31st	2025 August 31st	2026 August 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Preliminary
Cash and Equivalents
Cash and Short Term Investments	4,255	4,799	4,330	2,549	2,052
Prepaid Expenses
Total Other Current Assets
Total Current Assets	4,482	4,892	4,605	2,669	2,102
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8.16	4.42	2.74	0	0
Net Intangible Assets
Other Long Term Assets
Total Assets	4,499	4,909	4,632	2,681	2,114
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	221	408	471	244	189
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	221	408	471	244	189
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	4,278	4,501	4,161	2,437	1,926
Total Liabilities & Shareholders' Equity	4,499	4,909	4,632	2,681	2,114
Total Common Shares Outstanding